Platelet-rich plasma, shockwave therapy show therapeutic efficacy in interstitial cystitis
A study published in Frontiers in Bioengineering and Biotechnology found that combining platelet-rich plasma injections with low-intensity extracorporeal shock wave therapy effectively treats interstitial cystitis. Patients showed significant improvements in bladder symptoms and urodynamic parameters over a six-month period.
Why it matters
This research offers a potential non-invasive or minimally invasive therapeutic breakthrough for patients suffering from chronic bladder pain syndrome.
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source For patients with interstitial cystitis (IC)/bladder pain syndrome (BPS), the combination of platelet-rich plasma (PRP) and low-intensity extracorporeal shock wave therapy (LI-ESWT) shows therapeutic efficacy, according to a study recently published in Frontiers in Bioengineering and Biotechnology .
Cheng-Yu Long, from Kaohsiung Medical University in Taiwan, and colleagues performed LI-ESWT once a week for eight weeks in 25 female patients diagnosed with IC/BPS. In weeks 1, 5 and 9, high-dose PRP injections were administered. Baseline and one- and six-month posttreatment assessments were performed, including validated questionnaires and voiding diaries. At baseline and six-month follow-up, urodynamic studies were conducted.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in